« Previous
Next »
Titles
- Alirocumab for treatment of high cholesterol: effectiveness and value : new evidence update1
- Digital health technologies as an adjunct to medication assisted therapy for opioid use disorder: final evidence report and meeting summary1
- Nadofaragene firadenovec and oportuzumab monatox for BCG-unresponsive, non-muscle invasive bladder cancer: effectiveness and value : final report1
- Oral immunotherapy and Viaskin Peanut for peanut allergy: effectiveness and value : final evidence report1
- Siponimod for the treatment of secondary progressive multiple sclerosis: effectiveness and value : final evidence report1
- Supervised injection facilities and other supervised consumption sites: effectiveness and value : final report1
- Targeted immune modulators for ulcerative colitis: effectiveness and value : final evidence report and meeting summary1
- Valoctocogene roxaparvovec and emicizumab for hemophilia A without inhibitors: effectiveness and value : final report1